Maple, P.A.C.; Hosseini, A.A.
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective. Vaccines 2025, 13, 572.
https://doi.org/10.3390/vaccines13060572
AMA Style
Maple PAC, Hosseini AA.
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective. Vaccines. 2025; 13(6):572.
https://doi.org/10.3390/vaccines13060572
Chicago/Turabian Style
Maple, Peter A. C., and Akram A. Hosseini.
2025. "Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective" Vaccines 13, no. 6: 572.
https://doi.org/10.3390/vaccines13060572
APA Style
Maple, P. A. C., & Hosseini, A. A.
(2025). Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer’s Disease, and the Potential Benefits of Targeted Treatment or Vaccination—A Virological Perspective. Vaccines, 13(6), 572.
https://doi.org/10.3390/vaccines13060572